Randomized controlled trial

Cost-Effectiveness of Photobiomodulation for Intermediate Dry Age-Related Macular Degeneration: A Model-Based Analysis Using the LIGHTSITE III 24-Month Trial.

American journal of ophthalmology · 2026

Research data last refreshed
Source metadata

Publication record

PMID
42501959
Authors
Arjun Watane, Andre Witkin, Jeffrey Heier, Chirag Shah
Journal
American journal of ophthalmology
Publication types
Journal Article, Multicenter Study, Randomized Controlled Trial
DOI
10.1016/j.ajo.2026.07.035
Open primary PubMed record ↗